- cafead   Feb 28, 2022 at 09:42: AM
via Roche's Foundation Medicine leads the latest group of FDA breakthrough designations, securing the regulatory privileges for an assay designed to detect circulating tumor DNA (ctDNA) in plasma.
article source
article source